Atara Biotherapeutics Announces Executive and Board Changes
Ticker: ATRA · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1604464
| Field | Detail |
|---|---|
| Company | Atara Biotherapeutics, INC. (ATRA) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $520,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: ATRA
TL;DR
Atara Bio shakes up leadership and exec pay - new board members in, some execs out.
AI Summary
Atara Biotherapeutics, Inc. announced on October 14, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. Specific details regarding the individuals involved and the exact nature of the compensatory arrangements are outlined within the report.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy, operational focus, or financial outlook, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Atara Biotherapeutics, Inc. (company) — Registrant
- October 14, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 2380 Conejo Spectrum Street Suite 200 (address) — Principal Executive Offices
- Thousand Oaks, California (location) — City, State of Principal Executive Offices
- 91320 (zip_code) — Zip Code of Principal Executive Offices
- (805) 623-4211 (phone_number) — Registrant's Telephone Number
FAQ
What specific roles have been affected by the departures mentioned in the filing?
The filing indicates the departure of 'certain officers' and 'certain directors' but does not specify the exact roles within this 8-K.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated October 14, 2024.
What is the principal executive office address for Atara Biotherapeutics, Inc.?
The principal executive office is located at 2380 Conejo Spectrum Street, Suite 200, Thousand Oaks, California, 91320.
What is the company's state of incorporation?
Atara Biotherapeutics, Inc. is incorporated in Delaware.
What is the registrant's telephone number?
The registrant's telephone number is (805) 623-4211.
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-10-15 16:05:59
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share ATRA The Nasdaq Stock Mar
- $520,000 — ficer, his base salary was increased to $520,000 per year. There are no arrangements o
Filing Documents
- d729291d8k.htm (8-K) — 23KB
- 0001193125-24-237582.txt ( ) — 142KB
- atra-20241014.xsd (EX-101.SCH) — 3KB
- atra-20241014_lab.xml (EX-101.LAB) — 18KB
- atra-20241014_pre.xml (EX-101.PRE) — 11KB
- d729291d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATARA BIOTHERAPEUTICS, INC. Date: October 15, 2024 By: /s/ Amar Murugan Amar Murugan Chief Legal Officer